fig1
![Quantitative hepatitis B surface antigen in predicting recurrence of hepatitis B-related hepatocellular carcinoma after liver transplantation](https://image.oaes.cc/2af25a41-f32c-4695-8dec-a83b3410da79/2827.fig.1.png)
Figure 1. A: Cumulative incidence of HBsAg seroclearance after liver transplantation; B: cumulative incidence of the development of detectable anti-HBs after liver transplantation; C: cumulative incidence of recurrent hepatocellular carcinoma after transplantation